Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
New falsehoods claim that Dr. Sebi cured Magic Johnson of HIV. The truth is the basketball icon is thriving with the virus. Here’s how.
This year’s most widely viewed stories focused on HIV cure and vaccine news, long-acting treatment and coexisting conditions.
Infants treated within the first days of life can have a low viral reservoir, but most don’t receive antivirals so soon in the real world.
The HIV response is a shared global commitment to equitable health outcomes.
A new case raises questions about the keys to success for a functional cure after a stem cell transplant.
44% of children treated with two bnAbs maintained viral suppression after stopping antiretrovirals.
The experimental vaccine regimen trains the immune system to produce broadly neutralizing antibodies that target HIV.
Marc Franke is part of an exclusive circle of people cured of HIV after a stem cell transplant to treat cancer.
Gene therapy that alters CCR5 receptors and excises HIV from infected cells eliminated the virus in mice.
This may help expand the pool of available stem cells for curing HIV in people who require transplants for other medical conditions.
The video series by American Gene Technologies features interviews with HIV advocates, peer leaders, scientists, TikTokers and more.
EBT-101 is novel gene-editing therapy that uses “molecular scissors” to cut HIV out of cells.
The Cancer Cabinet was formed to mobilize all levers of the federal government to end cancer as we know it.
A new case may provide clues to help researchers develop strategies for a functional cure.
While the risky procedure is not suitable for most people living with HIV, it offers clues for more feasible approaches.
Held in person and virtually, AIDS 2022 is the world’s largest HIV-related gathering. From cure news to advocacy, here’s what to expect.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.